Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01917747 · ClinicalTrials.gov registry record · NA
Promoting Early Diagnosis of Congenital Hearing Loss With Patient Navigators
A NA study, sponsored by Matthew Bush, MD.
- Completed
- Registry status
- NA
- Development phase
- 106
- Enrollment target
NCT01917747 is a NA study that has completed, run by Matthew Bush, MD. The registered enrollment target is 106 participants.
The verdict
NCT01917747, a NA study, has completed, sponsored by Matthew Bush, MD.
- COMPLETED
- Registry status
- NA
- Development phase
- 106 participants
- Enrollment target
Study Summary
Hearing loss is the most common sensory congenital disorder and this condition is diagnosable and treatable. Children that are born with hearing loss have to undergo several hearing tests to diagnose the condition and many families are delayed in receiving this testing or never obtain the needed testing. This research employs a new method for helping children with hearing loss receive timely care by using a patient navigator, who is someone who teaches and provides emotional/social support for the families of these children. The hypothesis of this study is that a patient navigator will hasten the timing of pediatric audiological testing, improve compliance with scheduled appointments, and expand parental knowledge of pediatric hearing loss.
Interventions
- BEHAVIORAL Patient Navigator
- BEHAVIORAL Standard scheduling and follow-up
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 106 participants |
| Start Date | 2014-01-01 |
| Est. Completion | 2020-01-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01917747
The ClinicalTrials.gov registry entry for NCT01917747 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 106 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Matthew Bush, MD, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Patient Navigator is the first listed.
NCT01917747 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01917747 about?
NCT01917747 is a clinical study titled "Promoting Early Diagnosis of Congenital Hearing Loss With Patient Navigators". Hearing loss is the most common sensory congenital disorder and this condition is diagnosable and treatable. Children that are born with hearing loss have to undergo several hearing tests to diagnose the condition and many families are delayed in receiving this testing or never obtain the needed tes...
What is the current status of trial NCT01917747?
This trial is currently completed. It is a NA study. The enrollment target is 106 participants. The study started on 2014-01-01. Estimated completion is 2020-01-01.
What interventions are being tested in trial NCT01917747?
The interventions under investigation include: Patient Navigator (BEHAVIORAL), Standard scheduling and follow-up (BEHAVIORAL).
Who is sponsoring clinical trial NCT01917747?
This trial is sponsored by Matthew Bush, MD, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.